Setmelanotide Offers Significant, Long-Lasting Weight Loss

Although only a small number of patients meet the criteria for setmelanotide treatment, ongoing research could justify providing the drug to a broader population.

Related Keywords

France ,Paris ,France General ,French ,Christine Poitou ,European Medicines Agency ,French Pediatric Society ,Sorbonne University ,Trousseau Hospital ,Prof Christine Poitou ,Patients Has ,Genetic Form ,Obesity ,Bese ,Body Mass Index Bmi ,Genetics ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Genomics ,Genomic Medicine ,Edicine Genomic ,Pain Management ,Receptors ,Weight Loss ,Malignant Head And Neck Neoplasm ,Weight Management ,Hypothalmic ,Brain Tumor ,Abdominal Pain ,Diarrhea ,Abdomen ,Adolescent Medicine ,Adverse Effects ,Side Effects ,Brain ,Chemotherapy ,C ,